Anavex Life Sciences Corp (AVXL)

[blu_1]

clinicaltrials.gov didn't reveal dose of Avatar study. It said it's just 7 weeks. It said,

Intervention Model Description: 33 participants: 3 PK open-label followed by 30 double-blind, randomized, placebo-controlled.

Are the PK subjects used to establish max dosing for the entire trial's participants? I expect Avatar's results this spring.